<VariationArchive VariationID="1297102" VariationName="NM_001378454.1(ALMS1):c.833_834del (p.Phe278fs)" VariationType="Deletion" Accession="VCV001297102" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2021-10-02" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1286892" VariationID="1297102">
      <GeneList>
        <Gene Symbol="ALMS1" FullName="ALMS1 centrosome and basal body associated protein" GeneID="7840" HGNC_ID="HGNC:428" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="73385758" stop="73609919" display_start="73385758" display_stop="73609919" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_025791766.1" start="55253" stop="279417" display_start="55253" display_stop="279417" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73612885" stop="73837045" display_start="73612885" display_stop="73837045" Strand="+" />
          </Location>
          <OMIM>606844</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001378454.1(ALMS1):c.833_834del (p.Phe278fs)</Name>
      <CanonicalSPDI>NC_000002.12:73424497:TC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="73424498" stop="73424499" display_start="73424498" display_stop="73424499" variantLength="2" positionVCF="73424497" referenceAlleleVCF="TTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73651626" stop="73651627" display_start="73651626" display_stop="73651627" variantLength="2" positionVCF="73651625" referenceAlleleVCF="TTC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_015120.4:c.836_837del</Name>
      </OtherNameList>
      <ProteinChange>F278fs</ProteinChange>
      <ProteinChange>F279fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.73651626_73651627del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.73651626_73651627del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.73424498_73424499del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.73424498_73424499del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011690.1" sequenceAccession="NG_011690" sequenceVersion="1" change="g.43744_43745del">
            <Expression>NG_011690.1:g.43744_43745del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378454.1" sequenceAccession="NM_001378454" sequenceVersion="1" change="c.833_834del" MANESelect="true">
            <Expression>NM_001378454.1:c.833_834del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365383.1" sequenceAccession="NP_001365383" sequenceVersion="1" change="p.Phe278fs">
            <Expression>NP_001365383.1:p.Phe278fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015120.4" sequenceAccession="NM_015120" sequenceVersion="4" change="c.836_837del">
            <Expression>NM_015120.4:c.836_837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055935.4" sequenceAccession="NP_055935" sequenceVersion="4" change="p.Phe279fs">
            <Expression>NP_055935.4:p.Phe279fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_741" sequenceAccession="LRG_741">
            <Expression>LRG_741:g.43744_43745del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_741t1" sequenceAccession="LRG_741t1">
            <Expression>LRG_741t1:c.836_837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_741p1" sequenceAccession="LRG_741p1" change="p.Phe279fs">
            <Expression>LRG_741p1:p.Phe279fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1671340542" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001378454.1(ALMS1):c.833_834del (p.Phe278fs) AND Retinitis pigmentosa" Accession="RCV001724806" Version="3">
        <ClassifiedConditionList TraitSetID="6496">
          <ClassifiedCondition DB="MedGen" ID="C0035334">Retinitis pigmentosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001378454.1(ALMS1):c.833_834del (p.Phe278fs) AND Alstrom syndrome" Accession="RCV002227532" Version="4">
        <ClassifiedConditionList TraitSetID="1087">
          <ClassifiedCondition DB="MedGen" ID="C0268425">Alstrom syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-17" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2021-10-02" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17594715</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32037395</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34906470</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6496" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9558" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa</ElementValue>
                <XRef ID="CN038210" DB="ADAM" />
                <XRef ID="Retinitis+pigmentosa/6248" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019200" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
                <XRef ID="28835009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tapetoretinal degeneration</ElementValue>
                <XRef ID="HP:0000547" DB="Human Phenotype Ontology" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP</ElementValue>
                <XRef Type="MIM" ID="268000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal dominant, autosomal recessive and X linked inheritance</Attribute>
                <XRef ID="GTR000561973" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5694" />
                <XRef ID="5694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22234150</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Bakondi et al., 2015">
                <ID Source="PubMed">26666451</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C0035334" DB="MedGen" />
              <XRef ID="D012174" DB="MeSH" />
              <XRef ID="MONDO:0019200" DB="MONDO" />
              <XRef Type="MIM" ID="268000" DB="OMIM" />
              <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
              <XRef Type="secondary" ID="HP:0000547" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1087" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="207" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alstrom's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alstrom syndrome</ElementValue>
                <XRef ID="Alstrom+Syndrome/341" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008763" DB="MONDO" />
                <XRef ID="63702009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALMS</ElementValue>
                <XRef Type="MIM" ID="203800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALSS</ElementValue>
                <XRef Type="MIM" ID="203800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5787" />
                <XRef ID="5787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alström syndrome is characterized by cone-rod dystrophy, obesity, progressive bilateral sensorineural hearing impairment, acute infantile-onset cardiomyopathy and/or adolescent- or adult-onset restrictive cardiomyopathy, insulin resistance / type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and chronic progressive kidney disease. Cone-rod dystrophy presents as progressive visual impairment, photophobia, and nystagmus usually starting between birth and age 15 months. Many individuals lose all perception of light by the end of the second decade, but a minority retain the ability to read large print into the third decade. Children usually have normal birth weight but develop truncal obesity during their first year. Sensorineural hearing loss presents in the first decade in as many as 70% of individuals and may progress to the severe or moderately severe range (40-70 db) by the end of the first to second decade. Insulin resistance is typically accompanied by the skin changes of acanthosis nigricans, and proceeds to T2DM in the majority by the third decade. Nearly all demonstrate hypertriglyceridemia. Other findings can include endocrine abnormalities (hypothyroidism, hypogonadotropic hypogonadism in males, and hyperandrogenism in females), urologic dysfunction / detrusor instability, progressive decrease in renal function, and hepatic disease (ranging from elevated transaminases to steatohepatitis/NAFLD). Approximately 20% of affected individuals have delay in early developmental milestones, most commonly in gross and fine motor skills. About 30% have a learning disability. Cognitive impairment (IQ &lt;70) is very rare. Wide clinical variability is observed among affected individuals, even within the same family.</Attribute>
                <XRef ID="NBK1267" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301444</ID>
                <ID Source="BookShelf">NBK1267</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21522186</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES/PES/ESE, 2017">
                <ID Source="PubMed">28359099</ID>
                <ID Source="pmc">6283429</ID>
              </Citation>
              <XRef ID="64" DB="Orphanet" />
              <XRef ID="C0268425" DB="MedGen" />
              <XRef ID="MONDO:0008763" DB="MONDO" />
              <XRef Type="MIM" ID="203800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3831342" SubmissionDate="2021-09-29" DateLastUpdated="2021-10-02" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey="OGI1255_2|MedGen:C0035334" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001950205" DateUpdated="2021-10-02" DateCreated="2021-10-02" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">34906470</ID>
          </Citation>
          <Comment>The p.Phe278SerfsTer16 variant in ALMS1 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALMS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001378454.1:c.833_834del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0035334" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">34906470</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB9363246</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4903114" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="c9514d9c-912b-4b46-ae47-5855a625b5ca" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002507019" DateUpdated="2022-05-16" DateCreated="2022-05-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Phe278SerfsTer16 variant in ALMS1 was identified by our study in the compound heterozygous state, along with another pathogenic variant, in 1 individual with Alstrom syndrome. The variant has not been previously reported in individuals with Alstrom syndrome and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 278 and leads to a premature termination codon 16 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ALMS1 gene is an established disease mechanism in autosomal recessive Alstrom syndrome. The presence of this variant in combination with a reported pathogenic variants increases the likelihood that the p.Phe278SerfsTer16 variant is pathogenic (Variation ID: 550627). In summary, this variant meets criteria to be classified as pathogenic for Alstrom syndrome in an autosomal recessive manner based on the predicted impact of the variant, its absence from control populations, and its occurrence in trans with another pathogenic variant. ACMG/AMP Criteria applied: PVS1, PM2, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALMS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_015120.4:c.836_837del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.12:g.73424498_73424499del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008763" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431335</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8340185" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="5547290|MedGen:C0268425" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004551130" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32037395</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17594715</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with inherited retinal dystrophy (PMID: 32037395). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe279Serfs*16) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is also known as c.833_834delTC. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1297102).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALMS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.73651626_73651627del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268425" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3831342" TraitType="Disease" MappingType="XRef" MappingValue="C0035334" MappingRef="MedGen">
        <MedGen CUI="C0035334" Name="Retinitis pigmentosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8340185" TraitType="Disease" MappingType="XRef" MappingValue="C0268425" MappingRef="MedGen">
        <MedGen CUI="C0268425" Name="Alstrom syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4903114" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008763" MappingRef="MONDO">
        <MedGen CUI="C0268425" Name="Alstrom syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

